ABSI - NASDAQ

Absci Corporation

ABSI·NASDAQ

$5.94

-6.5%

HealthcareBiotechnology

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$926.08M

EPS-0.8400

P/E Ratio-7.07

Earnings Date08/11/2026

Available Earnings Call Transcripts

Select a year and quarter to view the full transcript.

Absci Corporation Earnings Call Transcripts

ABSI · NASDAQ

2026

May 7

N/A

N/A

Related Guides

Blog Categories

Continue your ABSI research with focused valuation guides.

Forecasting

Compare management guidance with modeled outcomes.

Risk Analysis

Track estimate risk, misses, and downside scenarios.

Reference

Review analyst process and transcript interpretation.

Value Investing

Anchor quarterly narrative to intrinsic value discipline.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.